Goldman Sachs

Goldman Sachs’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Goldman Sachs’s Portfolio CORV Stock Details CORV Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell
2018 Q3	$49K	Buy
2016 Q4	–	Sell
2016 Q3	$34K	Sell
2016 Q2	$57K	Buy
2015 Q2	–	Sell
2015 Q1	$117K	Buy